The manufacturers of Amitiza, a medication approved for IBS-C and CIC, have announced that the FDA no longer requires warnings regarding its use in pregnant and nursing women. The FDA still requires that caution should be taken when prescribing the medication to women who are breast-feeding. In addition, babies of nursing mothers who are taking the medication should be watched to make sure the babies are not experiencing diarrhea as a result of their mothers use of Amitiza.
"Sucampo Announces Approval of a Supplemental Application for Updates to AMITIZA (lubiprostone) Pregnancy Labeling" Sucampo website November 30, 2012.
Related Reading from Dr. Bolen, Your IBS Guide:
- Amitiza for Constipation
- Medicine for Constipation
- Pregnancy and Constipation Predominant IBS (IBS-C)
|Facebook | Twitter | Google+ | Newsletter Signup | Forum|